Collaborative care involving pharmacotherapy was cost effective for increasing anxiety free days in panic disorder

Katon, W. J.; Roy-Byrne, P.; Russo, J.
July 2003
Evidence Based Medicine;Jul2003, p126
Academic Journal
The article presents a study that compares the efficiency of collaborative care (CC) and usual care (UC) in the primary care of panic disorder patients in Alberta. Researchers randomized controlled trial of 115 panic disorder patients who are between 18 to 65 years old, where 57 of them are allocated to CC intervention while 58 to UC intervention. Moreover, they found that CC pharmacotherapy is cost efficient compared to UC.


Related Articles

  • Computer Therapy for the Anxiety and Depressive Disorders Is Effective, Acceptable and Practical Health Care: A Meta-Analysis. Andrews, Gavin; Cuijpers, Pim; Craske, Michelle G.; McEvoy, Peter; Titov, Nickolai // PLoS ONE;2010, Vol. 5 Issue 10, p1 

    Background: Depression and anxiety disorders are common and treatable with cognitive behavior therapy (CBT), but access to this therapy is limited. Objective: Review evidence that computerized CBT for the anxiety and depressive disorders is acceptable to patients and effective in the short and...

  • Cost-effectiveness of a primary care model for anxiety disorders. König, Hans-Helmut; Born, Anja; Heider, Dirk; Matschinger, Herbert; Heinrich, Sven; Riedel-Heller, Steffi G.; Surall, Daniel; Angermeyer, Matthias C.; Roick, Christiane; König, Hans-Helmut // British Journal of Psychiatry;Oct2009, Vol. 195 Issue 4, p308 

    Background: Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care.Aims: To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care.Method: In a...

  • Tailored internet-administered treatment of anxiety disorders for primary care patients: study protocol for a randomised controlled trial.  // Trials;2012, Vol. 13 Issue 1, p16 

    The article offers information on a randomised controlled trial conducted to examine the feasibility of the Internet-administered cognitive behavioural therapy (ICBT) for primary care patients with anxiety disorders . Researchers found that the long-term follow-up of the guided self-help is...

  • Overcoming Anxiety, Stress and Panic - A Five Areas Approach.  // Mental Health Practice;Jun2012, Vol. 15 Issue 9, p8 

    The article reviews the book "Overcoming Anxiety, Stress and Panic: A Five Areas Approach," by Chris Williams.

  • [Commentary on] Parent-child CBT reduces anxiety disorders among children aged 4-7 years. Dodd, Helen F.; Hudson, Jennifer L. // Evidence Based Mental Health;Feb2011, Vol. 14 Issue 1, p18 

    The article comments on a study on the use of parent-child cognitive behavior therapy (CBT) for anxiety disorders in children. It references the study "Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial," by Dina Hirshfeld-Becker et al....

  • rTMS Improves Generalized Anxiety Disorder Compared with Sham Treatment. Nierengarten, Mary Beth // MD Conference Express;Jun2014, Vol. 14 Issue 8, p21 

    Preliminary data indicate that repetitive transcranial magnetic stimulation (rTMS) is superior to a sham treatment for patients with generalized anxiety disorder (GAD). This article presents the results of an ongoing randomized controlled trial to assess the efficacy of rTMS versus sham...

  • Medication Dosing in Anxiety Disorders: What the Evidence Shows. White, Matthew P. // Primary Psychiatry;Oct2009, Vol. 16 Issue 10, p21 

    Social anxiety disorder, generalized anxiety disorder, and panic disorder are common and sometimes disabling conditions. While benzodiazepines, antidepressants, buspirone, and several anticonvulsants are frequently used to treat these conditions, an individual medication is often used as a...

  • On the receiving end. Osier, Tracy // Healthcare Counselling & Psychotherapy Journal;Jan2011, Vol. 11 Issue 1, p31 

    A personal narrative is presented which explores the author's experience of suffering from and being treated for anxiety.

  • Alprazolam.  // AHFS Consumer Medication Information;Aug2020, p1 

    Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics